Quarterly report · Q2
4182.TEDINET S100PJND
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥394.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥705.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥335.9bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥33.5bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥30.0bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥49.9bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥74.2bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥38.8bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥49.6bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥38.4bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥34.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥48.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥28.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥37.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥30.4bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥1.01T | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥928.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥867.3bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥337.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥297.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥675.7bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥630.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥609.3bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥101.4bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥102.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥91.8bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥92.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥71.0bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥91.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥13.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥52.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥23.5bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥30.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥65.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥31.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥5.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥15.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥166.33 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.67 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.15 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥135.5 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.5 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 60.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.3% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.3% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 31
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥73m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥70m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment ordinary income | 2022-04-01 → 2022-09-30 | −¥5m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥3.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥3.4bn |
| Reconciling Itemsreconciling | segment ordinary income | 2022-04-01 → 2022-09-30 | ¥3.7bn |
| jpcrp040300-q2r_E00815-000Basic Chemicals Business Sectorreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥236.4bn |
| jpcrp040300-q2r_E00815-000Basic Chemicals Business Sectorreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥233.0bn |
| jpcrp040300-q2r_E00815-000Basic Chemicals Business Sectorreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E00815-000Basic Chemicals Business Sectorreportable segment | segment ordinary income | 2022-04-01 → 2022-09-30 | ¥20.9bn |
| jpcrp040300-q2r_E00815-000Specialty Chemicals Business Sectorreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥161.9bn |
| jpcrp040300-q2r_E00815-000Specialty Chemicals Business Sectorreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥161.8bn |
| jpcrp040300-q2r_E00815-000Specialty Chemicals Business Sectorreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥58m |
| jpcrp040300-q2r_E00815-000Specialty Chemicals Business Sectorreportable segment | segment ordinary income | 2022-04-01 → 2022-09-30 | ¥25.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥137m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥128m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥8m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment ordinary income | 2021-04-01 → 2021-09-30 | ¥65m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥2.8bn |
| Reconciling Itemsreconciling | revenue external | 2021-04-01 → 2021-09-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥2.8bn |
| Reconciling Itemsreconciling | segment ordinary income | 2021-04-01 → 2021-09-30 | −¥1.2bn |
| jpcrp040300-q2r_E00815-000Basic Chemicals Business Sectorreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥200.9bn |
| jpcrp040300-q2r_E00815-000Basic Chemicals Business Sectorreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥198.2bn |
| jpcrp040300-q2r_E00815-000Basic Chemicals Business Sectorreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E00815-000Basic Chemicals Business Sectorreportable segment | segment ordinary income | 2021-04-01 → 2021-09-30 | ¥19.1bn |
| jpcrp040300-q2r_E00815-000Specialty Chemicals Business Sectorreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥137.6bn |
| jpcrp040300-q2r_E00815-000Specialty Chemicals Business Sectorreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥137.5bn |
| jpcrp040300-q2r_E00815-000Specialty Chemicals Business Sectorreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥48m |
| jpcrp040300-q2r_E00815-000Specialty Chemicals Business Sectorreportable segment | segment ordinary income | 2021-04-01 → 2021-09-30 | ¥20.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 555
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest and dividends income ope cf | CurrentYTDDuration | -2287000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 461000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 752000000 | JPY |
| Loss gain on sales of short term and long term investment securities ope cf | Prior1YTDDuration | -623000000 | JPY |
| Loss gain on sales of short term and long term investment securities ope cf | CurrentYTDDuration | -402000000 | JPY |
| Loss gain on valuation of short term and long term investment securities ope cf | Prior1YTDDuration | 144000000 | JPY |
| Loss gain on valuation of short term and long term investment securities ope cf | CurrentYTDDuration | 2000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -1053000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -1576000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -20588000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -13849000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 9435000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -6970000000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | 1267000000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | -1515000000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | Prior1YTDDuration | 12000000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | CurrentYTDDuration | -50000000 | JPY |
| Other net ope cf | Prior1YTDDuration | -9462000000 | JPY |
| Other net ope cf | CurrentYTDDuration | -14455000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 26124000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 15459000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 2262000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 2479000000 | JPY |
| Proceeds from dividends income from equity method affiliate ope cf | Prior1YTDDuration | 1736000000 | JPY |
| Proceeds from dividends income from equity method affiliate ope cf | CurrentYTDDuration | 8272000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -439000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -664000000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -6948000000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -12197000000 | JPY |
| Proceeds from insurance income ope cf | Prior1YTDDuration | 745000000 | JPY |
| Proceeds from insurance income ope cf | CurrentYTDDuration | 6000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 23479000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 13355000000 | JPY |
| Purchase of noncurrent assets inv cf | Prior1YTDDuration | -22740000000 | JPY |
| Purchase of noncurrent assets inv cf | CurrentYTDDuration | -32411000000 | JPY |
| Proceeds from sales of noncurrent assets inv cf | Prior1YTDDuration | 381000000 | JPY |
| Proceeds from sales of noncurrent assets inv cf | CurrentYTDDuration | 53000000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -474000000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -462000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 1376000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 518000000 | JPY |
| Payments of loans receivable inv cf | Prior1YTDDuration | -465000000 | JPY |
| Payments of loans receivable inv cf | CurrentYTDDuration | -1526000000 | JPY |
| Collection of loans receivable inv cf | Prior1YTDDuration | 58000000 | JPY |
| Collection of loans receivable inv cf | CurrentYTDDuration | 102000000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | -2668000000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | － | JPY |
| Other net inv cf | Prior1YTDDuration | -6537000000 | JPY |
| Other net inv cf | CurrentYTDDuration | 2908000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -31069000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |